Target the site of pain By applying focal pressure to the site of pain, our patented Counter-Traction Technology is directly tackling the site of inflammation
(2014) ARA 290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia response
At my Stamford, CT practice, I integrate BPC-157 into comprehensive treatment plans that include nutrition, rehabilitation, and other regenerative modalities
How BPC-157 May Help with Back Pain Back pain can be caused by a variety of factors, including muscle strains, ligament injuries, disc herniation, and degenerative conditions
A typical nasal TB-500 protocol might use 500-1000mcg daily during loading phases, dropping to 250-500mcg daily for maintenance